Quarterly Consolidated Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7580404

Concept As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2019-03-31
2018-04-01 to
2019-03-31
As at
2018-03-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-1,782,376,000 JPY
-1,468,048,000 JPY
Interest and dividends received
42,000 JPY
63,000 JPY
Income taxes paid
-2,127,000 JPY
-3,670,000 JPY
Net cash provided by (used in) operating activities
-1,784,461,000 JPY
-1,457,571,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-107,282,000 JPY
-173,164,000 JPY
Proceeds from sale of property, plant and equipment
495,000 JPY
JPY
Loan advances
JPY
-8,200,000 JPY
Proceeds from collection of loans receivable
JPY
10,000,000 JPY
Net cash provided by (used in) investing activities
-106,879,000 JPY
-185,115,000 JPY
Cash flows from financing activities
Net cash provided by (used in) financing activities
8,521,000 JPY
15,810,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,882,820,000 JPY
-1,626,876,000 JPY
Cash and cash equivalents
3,018,356,000 JPY
4,901,177,000 JPY
6,528,053,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.